Congenital stationary night blindness 1g is a genetic eye condition that mainly affects seeing in low light. People with this condition often struggle with night vision from birth or early childhood, and it usually does not get worse over time. Some may also have mild nearsightedness, eye shaking (nystagmus), or reduced depth perception, and not everyone will have the same experience. Vision in daylight is often near normal, and life expectancy is not affected. Treatment focuses on management, such as good lighting, vision aids, and regular eye care, and genetic testing can sometimes clarify the exact type.
Overview
Congenital stationary night blindness 1gSymptoms
Early signs of Congenital stationary night blindness 1g include lifelong trouble seeing in dim light, usually noticed in infancy or early childhood. Features may include reduced clarity, nystagmus, and nearsightedness or a squint. Daytime vision is near normal and nonprogressive.
Outlook and prognosis
Most people with congenital stationary night blindness 1g have lifelong trouble seeing in dim light, but daytime vision is usually stable. It doesn’t typically get worse over time. With lighting adjustments, low-vision aids, and regular eye care, many do well at school, work, and driving assessments.
Causes and risk factors
Congenital stationary night blindness 1g results from inherited changes in genes that affect how retinal cells pass signals in low light. Risk rises with a family history or parents being related; environmental or lifestyle factors are not known causes.
Genetic influences
Genetics play a central role in congenital stationary night blindness 1g. Variants in the NYX gene disrupt signaling between retina cells, causing lifelong night-vision problems from birth. Inherited in an X-linked pattern, it mainly affects males; females can be carriers with mild symptoms.
Diagnosis
Doctors suspect congenital stationary night blindness 1g from lifelong night-vision difficulty and characteristic clinical features on eye exam and electroretinography. Genetic tests confirm the genetic diagnosis of congenital stationary night blindness 1g; retinal imaging may support findings.
Treatment and drugs
Treatment for congenital stationary night blindness 1g focuses on improving vision in low light and supporting daily activities. Options may include optimized glasses, tinted lenses for glare, low‑vision aids, and orientation training; some benefit from amblyopia therapy in childhood. Regular follow‑up with ophthalmology helps tailor tools and monitor associated features like nystagmus or refractive errors.
Symptoms
Low-light settings are the main challenge for people with Congenital stationary night blindness 1g. The changes are often subtle at first, blending into daily life until they become more noticeable. In dim restaurants, at dusk, or in a movie theater, many find it harder to navigate or recognize faces, while daytime vision is often better. Parents or caregivers may wonder about early features of Congenital stationary night blindness 1g when a child struggles in the dark but otherwise sees reasonably well.
Difficulty seeing in dim light or at night is the hallmark feature of Congenital stationary night blindness 1g. This can make stairs, uneven ground, or finding things in a dark room harder.
Moving from bright to dark takes longer for the eyes to adjust. You may need extra time before vision settles after stepping into low light.
In Congenital stationary night blindness 1g, daytime vision is often near normal, though some have mildly reduced sharpness. Small print or distant signs may look a bit blurrier than expected.
Small, rapid eye movements (nystagmus) may appear in infancy or childhood. They can make it harder to fixate and may blur vision briefly.
How people usually first notice Congenital stationary night blindness 1g?
Many families first notice the first signs of congenital stationary night blindness 1g when a baby or young child seems unusually fearful or hesitant in dim light, struggles to see at dusk, or resists moving in dark rooms. Doctors are often alerted by poor night vision without progression, sometimes with rapid side-to-side eye movements (nystagmus) or mild nearsightedness, and they confirm it with an eye exam and tests that measure how the retina responds to light. In some cases, how congenital stationary night blindness is first noticed is through a routine pediatric eye check or school vision screening that prompts a referral to an eye specialist.
Types of Congenital stationary night blindness 1g
Congenital stationary night blindness 1g is a genetic eye condition with recognized clinical variants. These variants reflect differences in how the retinal signal pathway is affected, which can change how night vision, daytime clarity, and eye movements show up. Symptoms don’t always look the same for everyone. Knowing the variants of congenital stationary night blindness can help explain why one person mainly struggles to see in dim light while another also has daytime blur or color issues; people sometimes look up “types of congenital stationary night blindness” when sorting this out.
Complete CSNB
Night vision is very limited from birth, and bright light vision is usually better preserved. People may have nearsightedness and small to moderate eye shaking.
Incomplete CSNB
Night blindness is present, but daytime vision can also be reduced and color discrimination may be affected. Light sensitivity and nearsightedness are common.
X-linked CABP4
Night blindness begins early, and clarity in normal light may vary from near normal to mildly reduced. Some may have nystagmus and mild sensitivity to glare.
X-linked CACNA1F
Night blindness is marked, with reduced daytime sharpness and possible color issues. Nystagmus and high myopia are common in this variant.
Autosomal recessive GNAT1
Night vision is poor from infancy, while daytime vision is often near normal. Some experience mild light sensitivity without major color problems.
Autosomal recessive GRM6
Night blindness is prominent with stable, lifelong symptoms, and daytime acuity ranges from normal to mildly reduced. Nystagmus and moderate myopia can occur.
Autosomal recessive TRPM1
Night blindness is pronounced, and daytime vision can be mildly affected. People may have nearsightedness and subtle eye movement symptoms.
Autosomal recessive NYX
Night vision is severely reduced, with variable daytime clarity. Nystagmus is frequent, and color vision is often near normal.
Autosomal recessive LRIT3
Night blindness is early and lasting, with stable course over time. Daytime acuity is often mildly reduced, and myopia is common.
Autosomal recessive GPR179
Night blindness is strong and lifelong, and daytime vision may be mildly to moderately affected. Nystagmus and moderate nearsightedness are reported.
What genetics can tell you about symptoms
People with Congenital stationary night blindness 1g often struggle to see in low light, with lifelong night blindness and sometimes reduced sharpness. Variants in the NYX gene disrupt signaling between photoreceptors and bipolar cells, so rods can’t relay dim-light information properly.
Causes and risk factors
The main cause is a single-gene change that disrupts how the retina sends signals in low light. It is usually inherited from carrier parents and can rarely occur as a new change. Your chance is higher with a family history of Congenital stationary night blindness 1g or when both parents carry the same gene change. Lifestyle and environment do not cause this condition, but lighting, eye strain, and other eye problems can affect how early symptoms of Congenital stationary night blindness 1g are noticed. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
Congenital stationary night blindness 1g starts before birth and generally reflects built-in eye signaling differences rather than outside triggers. Doctors often group risks into internal (biological) and external (environmental). To date, clear environmental risk factors for congenital stationary night blindness 1g have not been identified. Below are biological and exposure-related points that may influence general birth risks, though most are not proven causes of this condition.
Older fathers have a higher chance of random changes arising in sperm cells. This slightly increases the chance of rare conditions that appear from birth. The overall risk for congenital stationary night blindness 1g remains very low.
Older maternal age is linked to some congenital conditions overall, though not specifically to this diagnosis. Large studies have not shown a clear association. Prenatal care helps track general risks.
Uncontrolled diabetes, severe malnutrition, or thyroid disease can affect fetal eye development. These have not been tied to this condition. Managing health conditions before and during pregnancy lowers overall risk.
Significant ionizing radiation exposure in pregnancy can harm eye development. Typical diagnostic imaging uses low doses and is considered safe when needed. There is no evidence it specifically causes this condition.
Genetic risk factors
Many families learn that Congenital stationary night blindness 1g is linked to changes in a single gene that helps pass signals from rods to the next cells in the retina. Some risk factors are inherited through our genes. These changes are present from birth and represent the primary genetic causes of Congenital stationary night blindness 1g.
ON-pathway gene: Harmful changes affect a gene that allows rod signals to reach ON-bipolar cells in the retina. This disconnect leads to night vision problems that start early and stay relatively stable.
Autosomal recessive pattern: Congenital stationary night blindness 1g usually appears when both copies of the gene carry a variant, one from each parent. Parents are typically healthy carriers, and each pregnancy has a 25% (1 in 4) chance to be affected.
Carriers: People with one variant generally have normal vision and are unlikely to have symptoms. Carrier testing can help relatives understand their chance of having a child with Congenital stationary night blindness 1g.
Variant types: Both missense changes and truncating variants can disrupt the gene. Many people have two different changes (compound heterozygous), yet the pathway effect is similar.
Genetic heterogeneity: Several different genes can cause congenital stationary night blindness, and testing helps pinpoint which one is involved. Confirming the exact gene can clarify prognosis and support accurate family counseling.
Population clustering: In some families or regions, one shared variant may be more frequent due to a distant common ancestor. This can make Congenital stationary night blindness 1g appear in multiple branches of the same family.
Variability: With two disease-causing variants, signs are typically present from birth, but how severe night vision difficulty is can differ. Differences likely reflect the exact variant combination and other genetic modifiers.
Lifestyle risk factors
Congenital stationary night blindness 1g is genetic and present from birth; lifestyle habits do not cause it. Still, daily choices can affect safety, visual comfort, and participation in activities, especially in dim environments. The points below illustrate how lifestyle affects Congenital stationary night blindness 1g in practical ways. Tailoring environments and routines can reduce accidents and visual strain.
Driving after dusk can compound impaired night vision and glare sensitivity in CSNB1G. Avoiding night driving or using planned routes, a helpful passenger, and slower speeds can reduce crash risk.
Dim hallways and bathrooms raise fall risk when night vision is poor. Install bright, even, motion-activated night lights to improve safe navigation at home.
Relying on ambient light outdoors can leave you effectively blind in darkness. Carry a headlamp or flashlight to restore contrast and depth cues in dark settings.
Alcohol further degrades contrast sensitivity and dark adaptation in CSNB1G. Limiting evening alcohol can improve safety and orientation in dim spaces.
Risk prevention
Congenital stationary night blindness 1g is present from birth, so you can’t prevent the condition itself. Prevention focuses on safety, vision support, and catching related issues early so day-to-day life is easier and safer. Prevention works best when combined with regular check-ups. Small changes to lighting, habits, and support at school or work can make a meaningful difference.
Schedule routine visits with an eye specialist to monitor vision, glasses needs, and eye alignment. Early treatment of crossed eyes or lazy eye can protect daytime vision and depth perception.
Use bright, even lighting at home, work, and school to reduce shadows and help with tasks. Keep nightlights in hallways and bathrooms, and carry a small torch/flashlight for dim places.
Try high-contrast materials, task lamps, magnifiers, and accessibility apps to make details easier to see. Tinted lenses or filters may reduce glare and improve contrast for some people.
Plan routes with good street lighting and avoid unlit areas when possible. Consider reflective clothing and avoid driving at night if visibility feels unsafe.
Transmission
Congenital stationary night blindness 1g is not infectious; it’s a lifelong, present‑from‑birth eye condition caused by changes in a single gene. The genetic transmission of Congenital stationary night blindness 1g is autosomal recessive, meaning a child needs to inherit one nonworking copy of the gene from each parent. Parents are usually healthy carriers, and when both carry the change, each pregnancy has a 25% (1 in 4) chance of a child with the condition, a 50% (1 in 2) chance of a carrier, and a 25% chance of neither. New changes in the gene can occur, but most cases follow this carrier‑to‑child pattern; a genetics professional can explain family‑specific risks and options.
When to test your genes
Consider genetic testing if you or a close relative have lifelong poor night vision, especially from early childhood, with normal daytime sight or a history of high myopia or nystagmus. Testing helps confirm diagnosis, guide eye care, anticipate inheritance risks, and tailor lighting or low-vision strategies. Seek testing before family planning or when symptoms affect safety.
Diagnosis
Congenital stationary night blindness 1g is typically identified by lifelong trouble seeing in low light, often noticed in early childhood, with daytime vision usually better preserved. Doctors usually begin with a detailed symptom history and eye exam, then add specialized tests to confirm the pattern. The genetic diagnosis of Congenital stationary night blindness 1g is made by combining these clinical clues with DNA testing. This approach helps confirm the type and guide family counseling.
Clinicians ask about lifelong night vision difficulties and how they affect activities like walking in dim hallways or seeing outside at dusk. Early symptoms of Congenital stationary night blindness 1g often start in childhood and stay relatively stable over time.
Standard vision charts, contrast sensitivity, and color tests help map out how day versus night vision is working. Results can be normal in bright light but reduced in low light, supporting a night-vision–specific problem.
A dilated eye exam checks the retina and optic nerve. Many people with Congenital stationary night blindness 1g have a normal-looking retina, so a normal exam does not rule it out.
An electroretinogram (ERG) measures how rod and cone cells respond to flashes of light. A characteristic pattern—markedly reduced rod responses with relatively better cone responses—supports the diagnosis.
Stages of Congenital stationary night blindness 1g
Congenital stationary night blindness 1g does not have defined progression stages. This condition is present from birth and typically stays stable over time, so vision difficulties usually don’t follow a stepwise decline. Doctors may diagnose it based on your history—early symptoms of congenital stationary night blindness 1g like trouble seeing in dim light—plus a careful eye exam, a retinal function test called an electroretinogram (ERG), and sometimes genetic testing. Early and accurate diagnosis helps you plan ahead with confidence.
Outlook and prognosis
Night driving, dim restaurants, or movie theaters are often the toughest moments for people with Congenital stationary night blindness 1g (CSNB1G). Many people ask, “What does this mean for my future?”, because the name sounds worrying, but “stationary” is key—the condition typically does not get worse over time. Prognosis refers to how a condition tends to change or stabilize over time. Most people with CSNB1G have lifelong trouble seeing in low light and may have reduced sharpness or depth perception, but daytime vision usually remains fairly steady.
Looking at the long-term picture can be helpful. CSNB1G does not shorten life expectancy, and it isn’t known to cause progressive vision loss or blindness later in life. Some people experience mild eye shaking or nearsightedness, while others notice only night vision issues; glasses or contacts can improve focus but won’t fix the low-light problem. Early symptoms of congenital stationary night blindness 1g often show up in childhood as fear of the dark, bumping into furniture at dusk, or struggling in dim classrooms.
In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Good lighting, high-contrast markings at home or work, and planning routes to avoid poorly lit areas can reduce daily hassles and falls. Most people can drive safely in daylight if they meet local vision standards, but night driving may not be practical or permitted. Talk with your doctor about what your personal outlook might look like, including whether tinted lenses, low-vision aids, or orientation-and-mobility training could help with evening activities.
Long-term effects
For many living with congenital stationary night blindness 1g, the long-term picture centers on how reliably they can see in low light. It’s important to remember that “long-term” doesn’t always mean “progressive.” Most features tend to remain stable over time, with challenges most noticeable at dusk, in dim rooms, or outdoors at night. Daytime vision is often usable, though some people notice mild limits that persist into adulthood.
Difficulty seeing in dim or nighttime settings usually starts in infancy and continues lifelong. Many families recall early symptoms of congenital stationary night blindness during evening routines or low‑lit rooms. These challenges generally remain steady rather than worsening.
Central vision in daylight is often near normal to mildly reduced and typically stable over the years. Fine detail may be a bit harder to pick up, especially at a distance. Changes over time are usually small.
Moving from bright to dim areas can take longer for the eyes to adjust. Glare sensitivity may add to the challenge when stepping into sunlight or facing headlights. These patterns tend to remain steady.
Small, involuntary eye movements often appear early in life. They commonly lessen with age, though mild movement can persist. Visual steadiness usually improves as children grow.
How is it to live with Congenital stationary night blindness 1g?
Living with congenital stationary night blindness 1g often means daytime vision is fairly steady, but low‑light settings feel like stepping into a dim room where details drop away and navigating takes extra care. Evenings out, movie theaters, or poorly lit hallways can be stressful, so many people plan ahead—using brighter lighting, a phone flashlight, high‑contrast cues, or a companion’s guidance until their eyes adjust. Friends, family, and coworkers may need simple accommodations like better lighting, clearer signage, or patience during dusk and nighttime transitions, which can make a big difference. Emotionally, it helps to name the challenge, advocate for light-friendly environments, and lean on tools and routines that keep life active and social.
Treatment and drugs
Treatment for congenital stationary night blindness 1g focuses on managing vision in low light and supporting daily activities rather than “fixing” night vision, which typically doesn’t improve with glasses alone. Although living with congenital stationary night blindness 1g can feel overwhelming, many people manage their symptoms and live fulfilling lives. Practical steps often help: brighter indoor lighting, motion‑activated night lights, high‑contrast markings on stairs, anti‑glare lenses, and sunglasses for daytime glare; children may benefit from school accommodations like preferential seating and extra time in dim rooms. An eye doctor may check for and treat any related issues—such as nearsightedness, astigmatism, or a “wandering eye”—with glasses, prisms, or, rarely, surgery for eye alignment; vitamin A or other supplements are not standard and should only be used if your doctor identifies a true deficiency. Ask your doctor about the best starting point for you, including a low‑vision evaluation and guidance on driving safety in dusk or nighttime conditions.
Non-drug treatment
Living with Congenital stationary night blindness 1g mainly affects seeing in low light and at night, so daily life often revolves around making dim environments safer and clearer. Supportive therapies can make a real difference in comfort, confidence, and independence. Families often notice early symptoms of Congenital stationary night blindness 1g in childhood, especially in movie theaters or at dusk, and simple adjustments can help right away. The options below focus on vision support, safety, and education rather than medicines.
Glasses or contact lenses can sharpen daytime vision and reduce eye strain. They do not fix night blindness but can make details clearer so you rely less on guesswork in dim light.
Brighter, even lighting at home, school, and work reduces tripping and eye fatigue. Task lights, motion sensors, and avoiding sharp shadows can make evenings and hallways easier to manage with Congenital stationary night blindness 1g.
Tinted or anti-reflective lenses can cut glare from headlights or screens. This may reduce squinting and improve comfort when moving between bright and dim areas.
A low-vision specialist can tailor tools like contrast-enhancing filters, magnifiers, and large-print or high-contrast settings. Training focuses on practical strategies to navigate dim spaces safely with Congenital stationary night blindness 1g.
Your genes may have an impact on how drugs work for you
Even with the same diagnosis, people can metabolize and respond to vision-related medications differently because gene variants act like dimmer switches on drug-processing enzymes. Pharmacogenetic testing may guide dosing or choice, but for many with CSNB1G, careful clinical monitoring remains most important.
Pharmacological treatments
There isn’t a proven medicine that restores night vision in congenital stationary night blindness 1g (CSNB1G). While early symptoms of congenital stationary night blindness 1g often show up in dim settings, medicines—when used—mainly target related issues like high myopia or nystagmus rather than the night vision itself. Not everyone responds to the same medication in the same way. Talk with your eye specialist about whether any of the options below fit your needs and goals.
No medication has been shown to improve night vision in CSNB1G. Care usually centers on glasses, good lighting, and vision rehabilitation.
Atropine eye drops (0.01–0.05%) may help slow worsening nearsightedness in children with CSNB1G. They are typically used once nightly and can cause mild light sensitivity or near-focus blur.
Gabapentin or memantine may reduce eye shaking and slightly steady vision in some people. These are off-label choices that can cause dizziness or sleepiness, so dosing is individualized and monitored.
Dorzolamide eye drops or oral acetazolamide can reduce retinal fluid if a doctor finds macular edema, which is uncommon in CSNB1G. Regular follow-up checks help track response and side effects like tingling or altered taste.
Genetic influences
In many families, changes in a single gene disturb how the retina’s night‑vision pathway relays signals from rod cells to the next layer of relay cells (bipolar cells), so difficulties are present from birth but usually do not worsen over time. For Congenital stationary night blindness 1g (CSNB1G), inheritance is usually autosomal recessive, meaning both biological parents silently carry one copy of the gene change and each child has a 25% (1 in 4) chance to be affected. A “carrier” means you hold the gene change but may not show symptoms. Because the affected gene works like a switch for this connection, different changes in it tend to cause similar night‑vision problems, sometimes alongside nearsightedness, yet the condition remains “stationary” rather than degenerative. Genetic testing can often confirm the cause and distinguish CSNB1G from other eye conditions, which is especially helpful when early symptoms of Congenital stationary night blindness 1g are noticed in childhood. Knowing the exact gene change can guide family planning and help relatives decide whether they want to be tested.
Is Congenital stationary night blindness 1g genetic?
Genetics play a central role in congenital stationary night blindness 1g. Variants in the NYX gene disrupt signaling between retina cells, causing lifelong night-vision problems from birth. Inherited in an X-linked pattern, it mainly affects males; females can be carriers with mild symptoms.
Pharmacogenetics—how genetics influence drug effects
For treatment planning, the specific gene change behind Congenital stationary night blindness 1g mostly guides diagnosis and what future options might fit, rather than driving day-to-day medication choices. Unlike conditions where genes change how the liver breaks down drugs and affect dosing, the CSNB1G gene alters how the retina sends signals in low light, so most routine medicines are used at standard doses. Doctors may still avoid or monitor medicines known to reduce night vision or stress the retina, such as high‑dose vitamin A derivatives or certain other eye‑affecting drugs, especially if dim‑light vision seemed worse after starting something new. Genetic testing for Congenital stationary night blindness 1g can connect you with clinical trials for gene‑directed therapies and helps set clear expectations about what current treatments can and can’t do. Advances in pharmacogenetics are helping link gene findings to more tailored care, but for CSNB1G that usually means choosing the right supportive tools (like lenses or low‑vision aids) rather than changing drug doses. Your care team will also weigh your age, vision needs, other eye findings, and overall health when discussing treatment options for Congenital stationary night blindness 1g.
Interactions with other conditions
Many living with congenital stationary night blindness 1g also have common eye issues such as nearsightedness (myopia) or astigmatism, which can make distance vision and low‑light situations even tougher. Doctors call it a “comorbidity” when two conditions occur together. If strabismus (eye misalignment) or amblyopia (sometimes called “lazy eye”) is present, the combination can further reduce clarity, so early vision correction and patching or therapy, when needed, can make a meaningful difference. Age‑related changes like cataracts later in life, or eye surface problems that cause glare and dryness, may also intensify night and dim‑light difficulties even though the underlying retinal condition itself does not usually progress. It’s rare, but a separate progressive retinal disease (for example, retinitis pigmentosa) could coexist; in that case, symptoms may build on one another and need close follow‑up with a retina specialist. Because early symptoms of congenital stationary night blindness 1g often prompt eye exams in childhood, it’s helpful to ask whether any other eye conditions are present and whether treatments for one might affect the other.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described trouble seeing in the dark long before there was a name for it. Families might recall a child who clung to the handrail at dusk or avoided dim movie theaters, while daytime vision looked fine. In many households, the pattern repeated across generations, suggesting that Congenital stationary night blindness 1g could run in families.
From early theories to modern research, the story of Congenital stationary night blindness 1g moved from observation to explanation. Early doctors grouped all “night blindness” together, not realizing there were several forms with different causes. As careful eye exams became standard, clinicians noticed a key feature: symptoms began in infancy or early childhood and did not steadily worsen over time. That “stationary” course set it apart from degenerative retinal diseases that tend to progress.
In recent decades, knowledge has built on a long tradition of observation. Detailed testing showed that the retina’s light-sensing network works, but the signal passing between its cells is altered, especially under low light. This helped explain why people with Congenital stationary night blindness 1g manage well in daylight but struggle at dusk or in dark rooms. Electroretinography and other tools gave a consistent pattern that matched what families had reported for generations.
Advances in genetics then clarified the picture. Researchers linked specific, inherited changes in genes that guide communication between retinal cells at the first relay point. This form, labeled “1g” to distinguish it from related types, reflects the particular gene involved and the way the condition is passed down within families. Genetic testing confirmed what earlier family trees hinted at, and it allowed more precise counseling about inheritance and recurrence risk.
Over time, medical classifications changed as the field learned to separate stationary night blindness into subtypes based on electrical testing, retinal findings, and the gene involved. Not every early description was complete, yet together they built the foundation of today’s knowledge. With this clearer history, the focus has shifted toward practical support—good lighting, safe night-time navigation, and school or workplace adjustments—while research continues to refine diagnosis and explore targeted therapies.